Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study.

Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2003 Sep 01; 21(17):3194-200.

View in: PubMed

subject areas

Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Combined Chemotherapy Protocols
Area Under Curve
Area Under Curve
Carboplatin
Carboplatin
Cisplatin
Cisplatin
Combined Modality Therapy
Combined Modality Therapy
Female
Female
Humans
Humans
Middle Aged
Middle Aged
Neoplasm Staging
Neoplasm Staging
Ovarian Neoplasms
Ovarian Neoplasms
Paclitaxel
Paclitaxel
Proportional Hazards Models
Proportional Hazards Models
Statistics, Nonparametric
Statistics, Nonparametric
Survival Analysis
Survival Analysis
Treatment Outcome
Treatment Outcome

authors with profiles

Robert S Mannel